Product Information
QC COUGH-COLD HBP TABLET is a generic product labeled by Chain Drug Marketing Association, priced at $0.1112 per EA under NDC 83324007224. Its NADAC has been published 96 times since Dec 4, 2024.
Strength
4; 30 mg/1; mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
83324007224
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
7/3/2024
Pharmacological Classes
Price Statistics
The NADAC for QC COUGH-COLD HBP TABLET has been published 96 times since Dec 4, 2024, and over the history we have for it it has risen 7.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1112 per EA |
|---|---|
| All-time high | $0.1114 (Sep 16, 2026) |
| All-time low | $0.0931 (Feb 19, 2025) |
| 52-week high | $0.1114 |
| 52-week low | $0.0954 |
| Median price | $0.1039 |
| Average price | $0.1033 |
| Largest weekly change | +9.6% (Dec 17, 2025) |
| Weeks tracked | 96 |
| Tracking since | Dec 4, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Chlorpheniramine maleate, Dextromethorphan HBr market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC COUGH-COLD HBP TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QC COUGH-COLD HBP TABLET, manufactured by Chain Drug Marketing Association, is $0.1112 per EA (NDC 83324007224), effective Sep 30, 2026.
How has the price of QC COUGH-COLD HBP TABLET changed over time?
Over the history we have for it, the NADAC for QC COUGH-COLD HBP TABLET has risen 7.0%. It has been tracked across 96 weekly CMS publications since Dec 4, 2024.
What are the highest and lowest recorded NADAC prices for QC COUGH-COLD HBP TABLET?
Since Dec 4, 2024, the NADAC for QC COUGH-COLD HBP TABLET has ranged from a low of $0.0931 (Feb 19, 2025) to a high of $0.1114 (Sep 16, 2026), with a median of $0.1039 per EA.
Are there cheaper alternatives to QC COUGH-COLD HBP TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as QC COUGH-COLD HBP TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures QC COUGH-COLD HBP TABLET?
QC COUGH-COLD HBP TABLET (NDC 83324007224) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.